Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 04-11-2022
The September 2022 quarter revenue stood at Rs. 41512.70 millions, up 8.57% as compared to Rs. 38234.50 millions during the corresponding quarter last year.The Company's Net profit for the September 2022 quarter have declined marginally to Rs. 7051.90 millions as against Rs. 7659.50 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 11533.30 millions from 11586.10 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 41512.70 | 38234.50 | 8.57 | 73084.00 | 73341.20 | -0.35 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 922.80 | 1977.30 | -53.33 | 2099.60 | 2773.90 | -24.31 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 11533.30 | 11586.10 | -0.46 | 21283.90 | 23563.90 | -9.68 | 40331.70 | 32976.90 | 22.30 |
| Interest | 75.00 | 76.00 | -1.32 | 97.10 | 156.00 | -37.76 | 269.30 | 450.70 | -40.25 |
| PBDT | 11458.30 | 11510.10 | -0.45 | 21186.80 | 23407.90 | -9.49 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1760.10 | 1389.70 | 26.65 | 2834.70 | 2529.40 | 12.07 | 4600.10 | 4686.20 | -1.84 |
| PBT | 9698.20 | 10120.40 | -4.17 | 18352.10 | 20878.50 | -12.10 | 35462.30 | 27840.00 | 27.38 |
| TAX | 2646.30 | 2460.90 | 7.53 | 4860.20 | 5333.90 | -8.88 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | -6.00 | 30.20 | -119.87 | -118.50 | -59.10 | 100.51 | -304.00 | -169.20 | 79.67 |
| PAT | 7051.90 | 7659.50 | -7.93 | 13491.90 | 15544.60 | -13.21 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1614.00 | 1613.30 | 0.04 | 1614.00 | 1613.30 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 27.78 | 30.30 | -8.32 | 29.12 | 32.13 | -9.36 | 30.81 | 29.18 | 5.59 |